News - Press Releases

Psynova Neurotech and Rules Based Medicine to co-develop a blood test for the diagnosis of schizophrenia

Cambridge, UK and Austin, TX (June 11 2008): Psynova Neurotech, a UK based company developing novel biomarkers to aid the diagnosis and treatment of neuropsychiatric illnesses, announced today it is partnering with Rules-Based Medicine, Inc. (RBM), the leading multiplexed biomarker testing laboratory, to co-develop and commercialise a blood test for the diagnosis of schizophrenia. [read PDF file]